The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders
Open accessThe DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index; 59 of the 246 sources its claims cite were checked for support.
Abstract
Autism spectrum disorder (ASD) is a group of complex neurodevelopmental conditions with a heterogeneous and multifactorial etiology that is not yet fully understood. Among the various factors that may contribute to ASD development, alterations in the gut microbiota have been increasingly recognized. Microorganisms in the gastrointestinal tract play a crucial role in the gut–brain axis (GBA), affecting nervous system development and behavior. Dysbiosis, or an imbalance in the microbiota, has been linked to both behavioral and gastrointestinal (GI) symptoms in individuals with ASD. The microbiota interacts with the central nervous system through mechanisms such as the production of short-chain fatty acids (SCFAs), the regulation of neurotransmitters, and immune system modulation. Alterations in its composition, including reduced diversity or an overabundance of specific bacterial taxa, have been associated with the severity of ASD symptoms. Dietary modifications, such as gluten-free or antioxidant-rich diets, have shown potential for improving gut health and alleviating behavioral symptoms. Probiotics, with their anti-inflammatory properties, may support neural health and reduce neuroinflammation. Fecal microbiota transplantation (FMT) is being considered, particularly for individuals with persistent GI symptoms. It has shown promising outcomes in enhancing microbial diversity and mitigating GI and behavioral symptoms. However, its limitations should be considered, as discussed in this narrative review. Further research is essential to better understand the long-term effects and safety of these therapies. Emphasizing the importance of patient stratification and phenotype characterization is crucial for developing personalized treatment strategies that account for individual microbiota profiles, genetic predispositions, and coexisting conditions. This approach could lead to more effective interventions for individuals with ASD. Recent findings suggest that gut microbiota may play a key role in innovative therapeutic approaches to ASD management.
Overview
CoChat Summary
TL;DR
This narrative review synthesizes evidence that gut microbiota dysbiosis and gut–brain axis dysfunction contribute to gastrointestinal and behavioral symptoms in autism spectrum disorder (ASD). It concludes that dietary interventions, probiotics, and fecal microbiota transplantation (FMT) show preliminary benefits but require personalized approaches and more rigorous long-term safety and efficacy data.
Key findings
- ASD affects around 1% of the global population and is diagnosed about four times more frequently in males than females; one-third of individuals with ASD have co-occurring intellectual disabilities, and 74% experience at least one co-occurring condition. GI conditions occur up to four times more frequently in children with ASD than in neurotypical peers, with prevalence rates ranging from 9% to 91%.
- ASD-associated dysbiosis includes a reduced Bacteroidetes/Firmicutes ratio, increased Lactobacillus species, and slight elevation in Desulfovibrio, which correlates with autism symptom severity; autistic children also show lower overall short-chain fatty acid levels, with a pronounced reduction in butyrate.
- In a study of 40 children with ASD aged 2–5 years, a whey-based supplement fortified with Bifidobacterium spp. and Lactobacillus spp. given daily for three months significantly increased stool colony counts of Bifidobacterium spp. (p = 0.000) and Lactobacillus spp. (p = 0.015); 80% of children had reduced anxiety and improved sleep, alongside better CARS and Pediatric Gastrointestinal Symptoms Questionnaire scores.
- A small open-label trial of microbiota transfer therapy in 18 children with ASD reported approximately 80% improvement in GI symptoms, sustained eight weeks after treatment; a two-year follow-up found most GI improvements maintained, continued positive behavioral progress, and increased bacterial diversity with higher Bifidobacteria and Prevotella.
Methods
- Narrative review; literature was selected through searches in PubMed and Google Scholar, including original research articles and systematic reviews based on recency and significance to the topic.
- Articles cited in tables included both original studies and review articles, with research conducted on both humans and animals.
- No formal systematic review, meta-analysis, or quantitative synthesis is described.
Limitations
- Stated: FMT limitations include lack of large-scale randomized controlled trials, uncertain long-term implications, variable individual responses due to microbiota/genetics/environment, and safety concerns such as infection risks and unintended microbiota changes.
- Stated: evidence for probiotics remains preliminary; further research is needed to identify effective strains, optimal dosages, and long-term safety profiles, and larger well-controlled trials and personalized probiotic treatments are required.
- Evident: as a narrative review, the selection criteria were based on recency and significance without a systematic protocol; the paper itself notes that diversity and heterogeneity of existing clinical studies challenge a robust evidence base, and microbiota findings for several taxa are conflicting.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
35 Valid · 2 Not valid · 118 Not checked · 7 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“A higher autism polygenic score (PGS) is linked to a lower likelihood of co-occurring developmental disabilities.”
§ The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders > 1. Introduction
What the sources say
- Disputedcites [9] Chawner, 2021, A Genetics-First Approach to Dissecting the Heterogeneity of Autism: Phenotypic Comparison of Autism Risk Copy Number Variants, Am. J. Psychiatry sourceExperimental — accuracy not yet measured
Our copy contains no polygenic-score analysis at all: the Discussion explicitly states that future work must investigate genetic factors 'including additional rare variants and polygenic risk, which we were not able to analyse in this study' (Discussion). All reported results concern CNV groups (16p11.2 del/dup, 22q11.2 del/dup) versus heterogeneous autism on ADI-R severity, domain/subdomain scores and FSIQ/VIQ/PIQ (Results, Aim 1 and Aim 2), and searches for 'polygenic score', 'PGS', 'polygenic risk' and 'developmental disability' returned only these passages plus references. The paper therefore contradicts rather than supports the attribution of an autism-PGS-to-developmental-disability association to it. (LLM, conf=0.80)
Checked by a reasoning model — may be wrong.
- Supportedcites [10] Warrier, 2022, Genetic Correlates of Phenotypic Heterogeneity in Autism, Nat. Genet. source
The Abstract states directly that 'higher autism polygenic scores (PGS) were associated with lower likelihood of co-occurring developmental disabilities in autistic individuals,' and the Results section 'Autism PGS and co-occurring developmental disabilities' (SPARK cohort, n = 13,435, quasi-Poisson regression) reports βPGS = −0.037, s.e. = 0.009, P = 3.91 × 10−5 for a reduced count of co-occurring developmental disabilities, holding after accounting for three other PGS. The source frames this as an association (with a possible contribution from the negative correlation with high-impact de novo variants), consistent with the citing sentence's hedged 'is linked to'. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Additionally, studies suggest a potential increase in the prevalence of Lactobacillus in the fecal samples of patients diagnosed with ASD [8,18,50,96,97,98,102,103,106,109,110,111].”
§ The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders > 3. The Association Between Gut Microbiota and the Development and Progression of Autism Spectrum Disorders (ASD) > 3.2. A Comparative Analysis of the Gut Microbiota in Patiens Diagnosed withASD and a Healthy Population
What the sources say
- Supportedcites [8] Fattorusso, A., Di Genova, L., Dell’Isola, G.B., Mencaroni, E., and Esposito, S. (2019). Autism Spectrum Disorders and the Gut Microbiota. Nutrients, 11. source
Section 3, “Dysbiosis in Autism Spectrum Disorder” (page not provided), discusses fecal microbiome findings and reports Lactobacillus as more abundant in children with ASD than in healthy children. The finding also applies to sibling controls, but the claim’s cautious wording does not imply that the increase is unique to ASD. (LLM, conf=0.91)
- Supportedcites [18] Strati, F., Cavalieri, D., Albanese, D., De Felice, C., Donati, C., Hayek, J., Jousson, O., Leoncini, S., Renzi, D., and Calabrò, A. (2017). New Evidences on the Altered Gut Microbiota in Autism Spectrum Disorders. Microbiome, 5. source
The Results section reports significantly greater relative abundance of Lactobacillus in autistic subjects than in neurotypical controls. The Methods section states that the study analyzed stool samples from enrolled subjects, supporting the claim’s reference to fecal samples. (LLM, conf=0.93)
- Disputedcites [50] De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D.I., Cristofori, F., Guerzoni, M.E., Gobbetti, M., and Francavilla, R. (2013). Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified. PLoS ONE, 8. sourceExperimental — accuracy not yet measured
The Results (Enumeration of cultivable bacteria, Table 3; page not provided) report lower counts of presumptive Enterococcus and Lactobacillus in autistic children than in healthy children, not an increase. The Introduction and Discussion describe differences in Lactobacillus composition but do not say it increased. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Dysbiosis can compromise this barrier, leading to increased intestinal permeability, commonly referred to as “leaky gut” syndrome (LGS).”
§ The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders > 2. Gut Microbiota and Gut–Brain Axis > 2.1. Gut–Brain Axis and Bacterial Metabolites
What the sources say
- Partly supportedcites [44] Odenwald, 2013, Intestinal Permeability Defects: Is It Time to Treat?, Clin. Gastroenterol. Hepatol. sourceExperimental — accuracy not yet measured
The Abstract describes barrier defects as increased intestinal permeability and discusses the term “leaky gut syndrome,” supporting those parts of the sentence. It does not say that dysbiosis compromises the barrier; its mention of microbiota describes them as luminal contents the barrier keeps from entering the body, not as a cause of barrier loss. (LLM, conf=0.84)
- Not checked yetcites [45] Wasiak, 2023, Intestinal Permeability and Its Significance in Psychiatric Disorders—A Narrative Review and Future Perspectives, Behav. Brain Res. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Dysbiosis, characterized by alterations in the gut microbiota composition, has been implicated in the gastrointestinal and neuropsychiatric symptoms of ASD, potentially through mechanisms involving immune dysregulation, increased intestinal permeability, and disrupted gut–brain communication [8].”
§ The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders > 1. Introduction
What the sources say
- Supportedcites [8] Fattorusso, A., Di Genova, L., Dell’Isola, G.B., Mencaroni, E., and Esposito, S. (2019). Autism Spectrum Disorders and the Gut Microbiota. Nutrients, 11. source
The Introduction (p. 1, §1) states that dysbiosis in children with ASD 'may contribute to both gastrointestinal and CNS symptoms' and links it to mucosal-barrier disruption with increased intestinal permeability, inflammatory cytokine production and disruption of gut-CNS signalling in the gut-brain axis. Section 4 (§4, 'Inflammation Hypothesis' and the following pages) elaborates the three mechanisms the claim names: dysbiosis altering gut permeability ('leaky gut') allowing LPS/toxin translocation, immune activation with raised proinflammatory cytokines modulating the CNS, and bidirectional neuroendocrine/neuroimmune-vagal gut-brain signalling affecting behaviour. The claim's hedge ('potentially') matches the review's own cautious wording, so the paraphrase is faithful. (LLM, conf=0.91)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Similarly, in the context of ASD, research findings are inconsistent [68,69].”
§ The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders > 2. Gut Microbiota and Gut–Brain Axis > 2.1. Gut–Brain Axis and Bacterial Metabolites
What the sources say
- Not checked yetcites [68] Kara, 2023, Serum Trimethylamine N-Oxide and Lipopolysaccharide Binding Protein Levels among Children Diagnosed with Autism Spectrum Disorder, Int. J. Dev. Neurosci. source
- Partly supportedcites [69] Quan, 2020, Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated with Autism Spectrum Disorders, Neurotoxicology sourceExperimental — accuracy not yet measured
The Results report higher plasma TMAO in children with ASD than in typically developing children, providing one finding relevant to the cited comparison. But the Introduction calls this the first study to directly examine TMAO and ASD, and the Discussion does not identify conflicting TMAO findings. This source alone therefore does not establish that findings on TMAO in ASD are inconsistent. (LLM, conf=0.83)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
70 more claims · 25 with their cited sources checked
Create a free account to see all 162 claims and to verify the 187 references still open.
- Probably not a substantial claim. 29
- It may state two separate claims as one. 72
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition to motor symptoms, children with ASD frequently experience comorbid sleep disturbances [27,28], feeding and eating disorders (FEEDs) [29,30], and gastrointestinal symptoms such as constipation [31].”
From The Prevalence and Clinical Significance of Toe Walking in Autism Spectrum Disorder: A Cross-Sectional Study in an Italian Pediatric Sample (2025) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders > 1. Introduction
“The gut microbiota composition in children with autism is characterized by a reduced Bacteroidetes/Firmicutes ratio, an increased abundance of Lactobacillus species, and a slight elevation in Desulfovibrio, which correlates with the severity of autism symptoms [17].”
§ The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders > 1. Introduction
“Alterations in the gut microbiota of individuals with ASD, including imbalances in the abundance of Gram-negative bacteria involved in sulfur metabolism, such as an increased presence of Bilophila and a decreased abundance of Desulfovibrio, may affect the availability of sulfur metabolites and disrupt the biochemical homeostasis of the body [17,18].”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders > 3. The Association Between Gut Microbiota and the Development and Progression of Autism Spectrum Disorders (ASD) > 3.2. A Comparative Analysis of the Gut Microbiota in Patiens Diagnosed withASD and a Healthy Population
“Ristori et al. revealed that individuals diagnosed with ASD exhibited a reduced population of bacteria from the Ruminococcus genus; however, numerous studies have demonstrated that the population of these bacteria could be augmented [101,107,109,110].”
§ The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders > 3. The Association Between Gut Microbiota and the Development and Progression of Autism Spectrum Disorders (ASD) > 3.2. A Comparative Analysis of the Gut Microbiota in Patiens Diagnosed withASD and a Healthy Population
“Furthermore, the research conducted by Coretti et al. and Ristori et al. suggests that, in patients diagnosed with ASD, there is not only an increase in the overall prevalence of Ruminococcus bacteria but also a potential elevation in the abundance of R. torques species [101,107].”
Citations
Cites
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513 · cited 1×
“…the predominance of specific bacterial species, leading to two primary enterotypes: one dominated by Bacteroides , prevalent in industrialized regions with low-fiber, high-fat diets, and another dominated by Prevotella , more common in regions with high-fiber, minimally processed diets [28,29].”
Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., & Gordon, J. I. (2007) · Nature · doi:10.1038/nature06244 · Cited by 6,091 · cited 1×
“The collective genetic material of these microbes is 100 times greater than the human genome, and their combined mass is estimated at 1 to 3 kg [23,24].”
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549 · cited 1×
“Butyrate plays a crucial role in regulating anti-inflammatory responses by controlling the expression of forkhead box protein P3 (Foxp3), essential for suppressing excessive inflammation [57].”
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“The collective genetic material of these microbes is 100 times greater than the human genome, and their combined mass is estimated at 1 to 3 kg [23,24].”
Global prevalence of autism: A systematic review update
Zeidan, J., Fombonne, E., Scorah, J., Ibrahim, A., Durkin, M. S., Saxena, S., Yusuf, A., Shih, A., & Elsabbagh, M. (2022) · Autism Research · doi:10.1002/aur.2696 · Cited by 3,117 · cited 1×
“The observed increase in prevalence may reflect heightened societal awareness, improved case identification, and evolving diagnostic criteria [4].”
Lai, M.-C., Lombardo, M. V., & Baron-Cohen, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61539-1 · Cited by 2,371
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
You are what you eat: Diet, health and the gut microbiota
Zmora, N., Suez, J., & Elinav, E. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0061-2 · Cited by 1,792
The enteric nervous system and neurogastroenterology
Furness, J. B. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.32 · Cited by 1,619 · cited 2×
“The autonomic nervous system and ENS regulate gut secretion, motility, and immune responses, all of which influence microbiota composition [42].”
An insight into gut microbiota and its functionalities
Adak, A., & Khan, M. R. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2943-4 · Cited by 1,485 · cited 1×
“Structurally, it maintains the integrity of the intestinal epithelium and supports cell regeneration [16].”
SCFA: mechanisms and functional importance in the gut
Martin-Gallausiaux, C., Marinelli, L., Blottière, H. M., Larraufie, P., & Lapaque, N. (2021) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006916 · Cited by 1,480
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391 · cited 2×
“Sequencing analyses revealed the partial engraftment of donor microbiota, increased bacterial diversity, and higher levels of beneficial taxa such as Bifidobacterium , Prevotella , and Desulfovibrio , which persisted following the intervention [134].”
Types and origins of bacterial membrane vesicles
Toyofuku, M., Nomura, N., & Eberl, L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0112-2 · Cited by 1,303
Astrocyte barriers to neurotoxic inflammation
Sofroniew, M. V. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3898 · Cited by 1,202 · cited 1×
“Astrocytes, which express TLR4 receptors, can initiate a pro-inflammatory response upon activation by LPS [78].”
Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice
Sharon, G., Cruz, N. J., Kang, D.-W., Gandal, M. J., Wang, B., Kim, Y.-M., Zink, E. M., Casey, C. P., Taylor, B. C., Lane, C. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.004 · Cited by 1,182
Short chain fatty acids in human gut and metabolic health
Blaak, E. E., Canfora, E. E., Theis, S., Frost, G., Groen, A. K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., et al. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0057 · Cited by 1,103
Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-22 · Cited by 1,076 · cited 2×
“The severity of GI disorders in children with ASD is closely linked to the intensity of neuropsychiatric symptoms, with more severe GI issues observed in individuals with more pronounced neuropsychiatric symptoms, and vice versa [14].”
New evidences on the altered gut microbiota in autism spectrum disorders
Strati, F., Cavalieri, D., Albanese, D., De Felice, C., Donati, C., Hayek, J., Jousson, O., Leoncini, S., Renzi, D., Calabrò, A., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0242-1 · Cited by 1,040 · cited 5×
“Additionally, there was a corresponding reduction in the number of bacteria from the Veillonella and Streptococcus genera, which are classified within these families [8,18,52,101,107,112,114,115].”
InfluentialPyrosequencing study of fecal microflora of autistic and control children
Finegold, S. M., Dowd, S. E., Gontcharova, V., Liu, C., Henley, K. E., Wolcott, R. D., Youn, E., Summanen, P. H., Granpeesheh, D., Dixon, D., et al. (2010) · Anaerobe · doi:10.1016/j.anaerobe.2010.06.008 · Cited by 977
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children
Kang, D.-W., Park, J. G., Ilhan, Z. E., Wallstrom, G., LaBaer, J., Adams, J. B., & Krajmalnik-Brown, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068322 · Cited by 976 · cited 4×
“Additionally, there was a corresponding reduction in the number of bacteria from the Veillonella and Streptococcus genera, which are classified within these families [8,18,52,101,107,112,114,115].”
InfluentialChen, Y., Xu, J., & Chen, Y. (2021) · Nutrients · doi:10.3390/nu13062099 · Cited by 917 · cited 1×
“…achieve the goals of restoring gut barrier integrity, enhancing SCFA production, modulating immune and inflammatory responses, neurotransmitter production, and improving gut microbial diversity, all of which are crucial for supporting gut health and alleviating ASD-related symptoms [114,139–144].”
De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D. I., Cristofori, F., Guerzoni, M. E., Gobbetti, M., & Francavilla, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076993 · Cited by 887 · cited 5×
“Additionally, SCFAs possess neuroprotective properties and, through epigenetic modifications, enhance memory formation and neural plasticity [49,50,55].”
InfluentialThe Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Tedelind, S., Westberg, F., Kjerrulf, M., & Vidal, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i20.2826 · Cited by 853 · cited 1×
“Acetate also exhibits anti-inflammatory properties, suppressing NF-κ B activation and lowering the production of pro-inflammatory mediators like lipopolysaccharide-induced TNF-α [62].”
Vaure, C., & Liu, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00316 · Cited by 842 · cited 1×
“…process results in the release of pro-inflammatory molecules and inter-leukins These bacterial toxins activate nuclear factor κ B (NF-κB), which, in conjunction with TLR4, regulates cytokine expression. inter-leukins as TNF-α , IL-6, IL-8, and IL-12, contributing to both local and systemic [46,47].”
Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration
Leeming, E. R., Johnson, A. J., Spector, T. D., & Le Roy, C. I. (2019) · Nutrients · doi:10.3390/nu11122862 · Cited by 817 · cited 1×
“While short-term dietary changes account for about 20% of microbiota variability, long-term eating habits exert a more profound impact [26,27].”
Mayer, E. A., Nance, K., & Chen, S. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042320-014032 · Cited by 813 · cited 1×
“This system encompasses interactions between the gut-associated immune system, the enteric nervous system (ENS), the vagus nerve, and microbial-derived products, including neurotransmitters, SCFAs, and bile acid derivatives [40,41].”
Modabbernia, A., Velthorst, E., & Reichenberg, A. (2017) · Molecular Autism · doi:10.1186/s13229-017-0121-4 · Cited by 809 · cited 1×
“Environmental risk factors, although still under investigation, include advanced parental age, birth complications associated with trauma, ischemia, and hypoxia, as well as, to a lesser extent, maternal obesity, maternal diabetes, and cesarean delivery [11].”
Autism risk factors: genes, environment, and gene-environment interactions
Chaste, P., & Leboyer, M. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.3/pchaste · Cited by 807 · cited 1×
“The etiology of ASD is multifactorial, involving complex interactions between ge-netic, epigenetic, and environmental factors, including immune dysregulation [5].”
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804 · cited 1×
“The gut microbiota, a diverse community of microorganisms inhabiting the gastrointestinal tract, begins to develop in the prenatal period, and disruptions in its composition during the first 2–3 years of life can negatively impact development and increase the risk of future diseases [15].”
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
Morgan, J. T., Chana, G., Pardo, C. A., Achim, C., Semendeferi, K., Buckwalter, J., Courchesne, E., & Everall, I. P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.024 · Cited by 749 · cited 1×
“These changes align with post-mortem studies of autistic individuals, in which studies have observed increased microglial activation and structural abnormalities [77].”
Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota
Kang, D.-W., Adams, J. B., Coleman, D. M., Pollard, E. L., Maldonado, J., McDonough-Means, S., Caporaso, J. G., & Krajmalnik-Brown, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-42183-0 · Cited by 749 · cited 2×
“These findings highlight the long-term safety and efficacy of MTT as a potential therapeutic option for children with ASD experiencing GI issues [135].”
Gastrointestinal Microflora Studies in Late‐Onset Autism
Finegold, S. M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M., Bolte, E., McTeague, M., Sandler, R., Wexler, H., Marlowe, E. M., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/341914 · Cited by 742 · cited 3×
“Additionally, there was a corresponding reduction in the number of bacteria from the Veillonella and Streptococcus genera, which are classified within these families [8,18,52,101,107,112,114,115].”
Kynurenine pathway metabolism and the microbiota-gut-brain axis
Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.002 · Cited by 724
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Dawin, E., Bader, V., Haase, S., Kaisler, J., David, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.035 · Cited by 644 · cited 1×
“Additionally, PA has been shown to modulate the immune system by significantly increasing the number of functional Treg cells while reducing Th1 and Th17 cell populations [56].”
Gastrointestinal microbiota in children with autism in Slovakia
Tomova, A., Husarova, V., Lakatosova, S., Bakos, J., Vlkova, B., Babinska, K., & Ostatnikova, D. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.10.033 · Cited by 632 · cited 2×
“Additionally, studies suggest a potential increase in the prevalence of Lactobacillus in the fecal samples of patients diagnosed with ASD [8,18,50,96–98, 102, 103, 106, 109– 111].”
The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity
González Hernández, M. A., Canfora, E. E., Jocken, J. W. E., & Blaak, E. E. (2019) · Nutrients · doi:10.3390/nu11081943 · Cited by 624 · cited 1×
“Moreover, acetate is essential for lipid metabolism and glucose regulation [59,60].”
Leaky Gut As a Danger Signal for Autoimmune Diseases
Mu, Q., Kirby, J., Reilly, C. M., & Luo, X. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00598 · Cited by 611 · cited 1×
“…process results in the release of pro-inflammatory molecules and inter-leukins These bacterial toxins activate nuclear factor κ B (NF-κB), which, in conjunction with TLR4, regulates cytokine expression. inter-leukins as TNF-α , IL-6, IL-8, and IL-12, contributing to both local and systemic [46,47].”
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota
Beam, A., Clinger, E., & Hao, L. (2021) · Nutrients · doi:10.3390/nu13082795 · Cited by 576 · cited 1×
“While short-term dietary changes account for about 20% of microbiota variability, long-term eating habits exert a more profound impact [26,27].”
Collective unconscious: How gut microbes shape human behavior
Dinan, T. G., Stilling, R. M., Stanton, C., & Cryan, J. F. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.021 · Cited by 571 · cited 1×
“Two free fatty acid receptors, FFA2 and FFA3, located in various brain regions, are bound by SCFAs [53].”
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate
Zhao, S., Jang, C., Liu, J., Uehara, K., Gilbert, M., Izzo, L., Zeng, X., Trefely, S., Fernandez, S., Carrer, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2101-7 · Cited by 553 · cited 1×
“In mice, dietary fructose is metabolized by gut microbes into acetate, serving as a source of acetyl-CoA for lipid synthesis [61].”
The Microbiota–Gut–Brain Axis in Psychiatric Disorders
Góralczyk-Bińkowska, A., Szmajda-Krygier, D., & Kozłowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911245 · Cited by 495
Autism Spectrum Disorders and the Gut Microbiota
Fattorusso, A., Di Genova, L., Dell’Isola, G., Mencaroni, E., & Esposito, S. (2019) · Nutrients · doi:10.3390/nu11030521 · Cited by 484 · cited 8×
“Additionally, there was a corresponding reduction in the number of bacteria from the Veillonella and Streptococcus genera, which are classified within these families [8,18,52,101,107,112,114,115].”
InfluentialGut Bacteria and Neurotransmitters
Dicks, L. M. T. (2022) · Microorganisms · doi:10.3390/microorganisms10091838 · Cited by 482 · cited 1×
“Beyond SCFAs and other metabolites, the gut microbiota influences central nervous system (CNS) activity by modulating the production and metabolism of neurotransmitters and bioactive molecules, including acetylcholine, catecholamines, histamine, and adeno-Nutrients sine [74].”
Dietary fiber and SCFAs in the regulation of mucosal immunity
Tan, J. K., Macia, L., & Mackay, C. R. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.007 · Cited by 421 · cited 2×
“…[46,47] . including butyrate and propionate, produced by gut bacteria via fiber fermentation exert widespread effects SCFAs, including butyrate and propionate, produced by gut bacteria via fiber fermentation, exert widespread effects. calcium absorption, and contribute to glucose homeostasis [48,49].”
Gut microbiota in autism and mood disorders
Mangiola, F. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i1.361 · Cited by 413 · cited 3×
“Ristori et al. revealed that individuals diagnosed with ASD exhibited a reduced population of bacteria from the Ruminococcus genus; however, numerous studies have demonstrated that the population of these bacteria could be augmented [101,107,109,110].”
The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder
Srikantha, P., & Mohajeri, M. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092115 · Cited by 400 · cited 10×
“Increased BBB permeability has been associated with heightened microglial activity and a reduction in astrocyte numbers and functionality [52,76].”
InfluentialDifferences in fecal microbial metabolites and microbiota of children with autism spectrum disorders
Kang, D.-W., Ilhan, Z. E., Isern, N. G., Hoyt, D. W., Howsmon, D. P., Shaffer, M., Lozupone, C. A., Hahn, J., Adams, J. B., & Krajmalnik-Brown, R. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2017.12.007 · Cited by 381 · cited 2×
“Additionally, studies suggest a potential increase in the prevalence of Lactobacillus in the fecal samples of patients diagnosed with ASD [8,18,50,96–98, 102, 103, 106, 109– 111].”
Williams, B. L., Hornig, M., Parekh, T., & Lipkin, W. I. (2012) · mBio · doi:10.1128/mbio.00261-11 · Cited by 378
Relationship between the gut microbiome and brain function
Mohajeri, M. H., La Fata, G., Steinert, R. E., & Weber, P. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy009 · Cited by 376 · cited 1×
“Additionally, SCFAs possess neuroprotective properties and, through epigenetic modifications, enhance memory formation and neural plasticity [49,50,55].”
A prebiotic intervention study in children with autism spectrum disorders (ASDs)
Grimaldi, R., Gibson, G. R., Vulevic, J., Giallourou, N., Castro-Mejía, J. L., Hansen, L. H., Leigh Gibson, E., Nielsen, D. S., & Costabile, A. (2018) · Microbiome · doi:10.1186/s40168-018-0523-3 · Cited by 369 · cited 1×
“Dietary interventions show potential in improving gut health and reducing inflammation, which may alleviate ASD symptoms [119,124,125].”
Intestinal Permeability Defects: Is It Time to Treat?
Odenwald, M. A., & Turner, J. R. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.001 · Cited by 366 · cited 2×
“Within the body, LPS is recognized by Toll-like LGS allows microbial components like lipopolysaccharide (LPS), toxic metabolites, and inflammatory agents to enter the blood-stream [44,45]. receptors (TLRs), particularly belong to the pattern recognition receptors (PPR) family.”
Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity
Kinashi, Y., & Hase, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673708 · Cited by 356 · cited 1×
“Furthermore, increased intestinal permeability can activate T-cells, potentially triggering autoimmune disorders in the gut or other organs as these activated lymphocytes circulate throughout the body [88].”
Gut Microbiota and Chronic Constipation: A Review and Update
Ohkusa, T., Koido, S., Nishikawa, Y., & Sato, N. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00019 · Cited by 354 · cited 2×
“An overview of the variables impacting the microbiome makeup in adults is provided in Figure 1 [31–39].”
Iglesias-Vázquez, L., Van Ginkel Riba, G., Arija, V., & Canals, J. (2020) · Nutrients · doi:10.3390/nu12030792 · Cited by 352 · cited 2×
“Strati et al. demonstrated a decline in the presence of Parabacteroides in a population with ASD; nevertheless, numerous scientific studies have indicated that the abundance of this bacterium, particularly P. distasonis , should be elevated in comparison to healthy populations [18,52,89,101,113].”
The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?
Misiak, B., Łoniewski, I., Marlicz, W., Frydecka, D., Szulc, A., Rudzki, L., & Samochowiec, J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109951 · Cited by 343 · cited 1×
“This disruption results in the increased production of glucocorticoids and catecholamines, causing hypercortisolemia and HPA axis overactivation, often accompanied by impaired glucocorticoid receptor function [85,86].”
Liu, F., Li, J., Wu, F., Zheng, H., Peng, Q., & Zhou, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0389-6 · Cited by 336 · cited 4×
“Additionally, studies suggest a potential increase in the prevalence of Lactobacillus in the fecal samples of patients diagnosed with ASD [8,18,50,96–98, 102, 103, 106, 109– 111].”
InfluentialBrain-Gut-Microbiota Axis and Mental Health
Dinan, T. G., & Cryan, J. F. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000519 · Cited by 325
Autism spectrum disorders and intestinal microbiota
De Angelis, M., Francavilla, R., Piccolo, M., De Giacomo, A., & Gobbetti, M. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1035855 · Cited by 311
Blood-brain barrier regulation in psychiatric disorders
Kealy, J., Greene, C., & Campbell, M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.033 · Cited by 307 · cited 1×
“However, low-grade systemic inflammation associated with LGS damages the BBB, a critical structure responsible for brain homeostasis and proper neuronal function [75].”
Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction
Boini, K. M., Hussain, T., Li, P.-L., & Koka, S. S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000484623 · Cited by 302
Comorbidities in autism spectrum disorder and their etiologies
Khachadourian, V., Mahjani, B., Sandin, S., Kolevzon, A., Buxbaum, J. D., Reichenberg, A., & Janecka, M. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02374-w · Cited by 291 · cited 1×
“These comorbidities include attention deficit hyperactivity disorder (ADHD), anxiety disorders, epilepsy, obsessive–compulsive disorder (OCD), sleep disturbances, sensory processing issues, motor coordination difficulties, and gastrointestinal (GI) disorders [12].”
The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior
Arentsen, T., Qian, Y., Gkotzis, S., Femenia, T., Wang, T., Udekwu, K., Forssberg, H., & Diaz Heijtz, R. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.182 · Cited by 280 · cited 1×
“These findings suggest that PGN may directly impact neuronal function [83,84].”
Gut Microbiota Features in Young Children With Autism Spectrum Disorders
Coretti, L., Paparo, L., Riccio, M. P., Amato, F., Cuomo, M., Natale, A., Borrelli, L., Corrado, G., De Caro, C., Comegna, M., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03146 · Cited by 266 · cited 8×
“Furthermore, the research conducted by Coretti et al. and Ristori et al. suggests that, in patients diagnosed with ASD, there is not only an increase in the overall prevalence of Ruminococcus bacteria but also a potential elevation in the abundance of R. torques species [101,107].”
InfluentialThe Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Rahman, M. M., Islam, F., -Or-Rashid, M. H., Mamun, A. A., Rahaman, M. S., Islam, M. M., Meem, A. F. K., Sutradhar, P. R., Mitra, S., Mimi, A. A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.903570 · Cited by 253
Gut microbiota in the pathogenesis and therapeutic approaches of diabetes
Crudele, L., Gadaleta, R. M., Cariello, M., & Moschetta, A. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104821 · Cited by 251
Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions
Ristori, M. V., Quagliariello, A., Reddel, S., Ianiro, G., Vicari, S., Gasbarrini, A., & Putignani, L. (2019) · Nutrients · doi:10.3390/nu11112812 · Cited by 214 · cited 6×
“Furthermore, the research conducted by Coretti et al. and Ristori et al. suggests that, in patients diagnosed with ASD, there is not only an increase in the overall prevalence of Ruminococcus bacteria but also a potential elevation in the abundance of R. torques species [101,107].”
InfluentialMicrobiology of regressive autism
Finegold, S. M., Downes, J., & Summanen, P. H. (2012) · Anaerobe · doi:10.1016/j.anaerobe.2011.12.018 · Cited by 211
Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation
Taniya, M. A., Chung, H.-J., Al Mamun, A., Alam, S., Aziz, M. A., Emon, N. U., Islam, M. M., Hong, S.-T. S., Podder, B. R., Ara Mimi, A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.915701 · Cited by 207 · cited 1×
“Research suggests that those who may benefit the most include individuals with ASD experiencing chronic GI issues such as persistent constipation, diarrhea, bloating, or irritable bowel syndrome (IBS)-like symptoms [130].”
Cecil, J. D., O’Brien-Simpson, N. M., Lenzo, J. C., Holden, J. A., Singleton, W., Perez-Gonzalez, A., Mansell, A., & Reynolds, E. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01017 · Cited by 199 · cited 1×
“This leads to monocyte and macrophage activation, causing inflammatory cell death and tissue damage both in vitro and in vivo [81].”
Desulfovibrio species are potentially important in regressive autism
Finegold, S. M. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.04.032 · Cited by 197 · cited 1×
“Additionally, studies suggest a potential increase in the prevalence of Lactobacillus in the fecal samples of patients diagnosed with ASD [8,18,50,96–98, 102, 103, 106, 109– 111].”
Acetate and Butyrate Improve β-cell Metabolism and Mitochondrial Respiration under Oxidative Stress
Hu, S., Kuwabara, R., de Haan, B. J., Smink, A. M., & de Vos, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041542 · Cited by 189 · cited 1×
“Moreover, acetate is essential for lipid metabolism and glucose regulation [59,60].”
Development of Gut Microbiota in the First 1000 Days after Birth and Potential Interventions
Pantazi, A. C., Bălașa, A. L., Mihai, C. M., Chisnoiu, T., Lupu, V. V., Kassim, M. A. K., Mihai, L., Frecuș, C. E., Chirila, S. I., Lupu, A., et al. (2023) · Nutrients · doi:10.3390/nu15163647 · Cited by 183
Wang, M., Wan, J., Rong, H., He, F., Wang, H., Zhou, J., Cai, C., Wang, Y., Xu, R., Yin, Z., et al. (2019) · mSystems · doi:10.1128/msystems.00321-18 · Cited by 181
Microbiota revolution: How gut microbes regulate our lives
Colella, M., Charitos, I. A., Ballini, A., Cafiero, C., Topi, S., Palmirotta, R., & Santacroce, L. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i28.4368 · Cited by 179 · cited 2×
“This harmonious relationship, known as eubiosis, is essential for overall well-being and stands in contrast to dysbiosis—a state of imbalance in the microbiota’s composition and function [20,21].”
The lifetime social cost of autism: 1990–2029
Cakir, J., Frye, R. E., & Walker, S. J. (2020) · Research in Autism · doi:10.1016/j.rasd.2019.101502 · Cited by 177 · cited 1×
“…public health concern and the fastest-growing developmental disorder, generating annual costs of USD 236–262 billion in the USA, with an estimated lifetime social cost of approximately USD 3.6 million per individual; by 2029, total social costs are projected to exceed USD 11.5 trillion [2,3].”
InfluentialImmune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
Robinson-Agramonte, M. D. L. A., Noris García, E., Fraga Guerra, J., Vega Hurtado, Y., Antonucci, N., Semprún-Hernández, N., Schultz, S., & Siniscalco, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063033 · Cited by 176 · cited 1×
“Upregulated inflammatory cytokines have been closely associated with ASD behavioral symptoms [138].”
Regulation, risk and safety of Faecal Microbiota Transplant
Merrick, B., Allen, L., Masirah M Zain, N., Forbes, B., Shawcross, D. L., & Goldenberg, S. D. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100069 · Cited by 171 · cited 1×
“Further research is essential to validate the efficacy, safety, and long-term effects of FMT in ASD, as well as to better understand its mechanisms, individual variability, and other challenges [136,137].”
How Diet and Physical Activity Modulate Gut Microbiota: Evidence, and Perspectives
Campaniello, D., Corbo, M. R., Sinigaglia, M., Speranza, B., Racioppo, A., Altieri, C., & Bevilacqua, A. (2022) · Nutrients · doi:10.3390/nu14122456 · Cited by 167 · cited 1×
“…the predominance of specific bacterial species, leading to two primary enterotypes: one dominated by Bacteroides , prevalent in industrialized regions with low-fiber, high-fat diets, and another dominated by Prevotella , more common in regions with high-fiber, minimally processed diets [28,29].”
Gastrointestinal Issues and Autism Spectrum Disorder
Madra, M., Ringel, R., & Margolis, K. G. (2020) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2020.02.005 · Cited by 159 · cited 1×
“GI conditions occur up to four times more frequently in children with ASD than in neurotypical peers, with prevalence rates ranging from 9% to 91% [13].”
Abdulqadir, R. F., Engers, J., & Al–Sadi, R. (2023) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2023.102026 · Cited by 154
Genetic correlates of phenotypic heterogeneity in autism
Warrier, V., Zhang, X., Reed, P., Havdahl, A., Moore, T. M., Cliquet, F., Leblond, C. S., Rolland, T., Rosengren, A., LEAP, E.-A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01072-5 · Cited by 152 · cited 1×
“Additionally, nearly half of the individuals with CNVs who did not meet the full diagnostic criteria for ASD exhibited elevated autistic traits, suggesting a continuum between the autism spectrum and the general population [9,10].”
Kong, X.-J., Liu, J., Liu, K., Koh, M., Sherman, H., Liu, S., Tian, R., Sukijthamapan, P., Wang, J., Fong, M., et al. (2021) · Nutrients · doi:10.3390/nu13051552 · Cited by 150 · cited 1×
“Moreover, enhanced gut microbiome hubs, particularly the Eubacterium hallii group, were positively correlated with improved social cognition [128].”
Xie, J., Cools, L., Van Imschoot, G., Van Wonterghem, E., Pauwels, M. J., Vlaeminck, I., De Witte, C., EL Andaloussi, S., Wierda, K., De Groef, L., et al. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12306 · Cited by 149 · cited 1×
“This interaction activates glial cells, disrupts neuronal function, and accelerates amyloid-β pathology, ultimately contributing to cognitive decline [82].”
Dysbiosis: from fiction to function
Tiffany, C. R., & Bäumler, A. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00230.2019 · Cited by 148 · cited 1×
“This harmonious relationship, known as eubiosis, is essential for overall well-being and stands in contrast to dysbiosis—a state of imbalance in the microbiota’s composition and function [20,21].”
Madore, C., Leyrolle, Q., Lacabanne, C., Benmamar-Badel, A., Joffre, C., Nadjar, A., & Layé, S. (2016) · Neural Plasticity · doi:10.1155/2016/3597209 · Cited by 141 · cited 1×
“Brain inflammation caused by these disruptions can lead to abnormal synapse function and stimulate the release of vasopressin, a biomarker of ASD known to affect social behavior [79].”
Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders
Li, D., Yu, S., Long, Y., Shi, A., Deng, J., Ma, Y., Wen, J., Li, X., Liu, S., Zhang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.985378 · Cited by 129 · cited 1×
“This disruption can cause structural and functional damage to the central nervous system, as the QUIN overactivation of NMDA receptors leads to excessive stimulation, while excessive KYNA, despite its neuroprotective role, contributes to neurodegeneration and cognitive decline [71–73].”
Wang, T., Chen, B., Luo, M., Xie, L., Lu, M., Lu, X., Zhang, S., Wei, L., Zhou, X., Yao, B., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01656-1 · Cited by 118
Bacterial Peptidoglycans from Microbiota in Neurodevelopment and Behavior
Gonzalez-Santana, A., & Diaz Heijtz, R. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.05.003 · Cited by 118
The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression
Rudzki, L., & Maes, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01961-y · Cited by 111 · cited 1×
“Increased BBB permeability has been associated with heightened microglial activity and a reduction in astrocyte numbers and functionality [52,76].”
Başpınar, B., & Yardımcı, H. (2020) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2020.19230 · Cited by 110 · cited 1×
“Dietary interventions show potential in improving gut health and reducing inflammation, which may alleviate ASD symptoms [119,124,125].”
The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder
Młynarska, E., Gadzinowska, J., Tokarek, J., Forycka, J., Szuman, A., Franczyk, B., & Rysz, J. (2022) · Nutrients · doi:10.3390/nu14091921 · Cited by 109 · cited 1×
“Examples of these metabolic products include SCFAs, which are produced by Lacto-bacillus , Bifidobacterium, and Prevotella [93].”
Self-citationA Ketogenic Diet and the Treatment of Autism Spectrum Disorder
Li, Q., Liang, J., Fu, N., Han, Y., & Qin, J. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.650624 · Cited by 107
Quan, L., Xu, X., Cui, Y., Han, H., Hendren, R. L., Zhao, L., & You, X. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab073 · Cited by 104
Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota
Settanni, C. R., Bibbò, S., Ianiro, G., Rinninella, E., Cintoni, M., Mele, M. C., Cammarota, G., & Gasbarrini, A. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1869938 · Cited by 98 · cited 3×
“Studies has shown a significant increase in the prevalence of Clostridium bacteria in ASD patients compared to the general population [8,50,52,96–109].”
Dargenio, V. N., Dargenio, C., Castellaneta, S., De Giacomo, A., Laguardia, M., Schettini, F., Francavilla, R., & Cristofori, F. (2023) · Nutrients · doi:10.3390/nu15071620 · Cited by 98 · cited 10×
“The populations of Roseburia and Turicibacter have been described as elevated in individuals with ASD by Srikantha et al. and Dargenio et al.; nevertheless, other authors have demonstrated that the population of these bacteria should be decreased [52,89,103,111].”
InfluentialWiggins, L. D., Rice, C. E., Barger, B., Soke, G. N., Lee, L.-C., Moody, E., Edmondson-Pretzel, R., & Levy, S. E. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01674-1 · Cited by 95 · cited 2×
“Severe forms of ASD are linked to a substantial economic burden, parental stress, and numerous co-occurring medical and behavioral issues [2].”
InfluentialChawner, S. J. R. A., Doherty, J. L., Anney, R. J. L., Antshel, K. M., Bearden, C. E., Bernier, R., Chung, W. K., Clements, C. C., Curran, S. R., Cuturilo, G., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20010015 · Cited by 95
Analysis of the Duodenal Microbiome in Autistic Individuals: Association With Carbohydrate Digestion
Kushak, R. I., Winter, H. S., Buie, T. M., Cox, S. B., Phillips, C. D., & Ward, N. L. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001458 · Cited by 92 · cited 5×
“Additionally, there was a corresponding reduction in the number of bacteria from the Veillonella and Streptococcus genera, which are classified within these families [8,18,52,101,107,112,114,115].”
InfluentialGe, P., Duan, H., Tao, C., Niu, S., Hu, Y., Duan, R., Shen, A., Sun, Y., & Sun, W. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s399480 · Cited by 78 · cited 1×
“Additionally, TMAO promotes the activation of the NLRP3 microglial inflammasome, exacerbating neurological damage in ischemic stroke [66].”
Systematic Review: Autism Spectrum Disorder and the Gut Microbiota
Korteniemi, J., Karlsson, L., & Aatsinki, A. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13587 · Cited by 77 · cited 4×
“In addition, the presence of Staphylococcus , Coprococcus , Lactococcus , and Flavonifractor may be detected in lower quantities [8,52,107,111,114,115].”
InfluentialShort-chain fatty acids: Important components of the gut-brain axis against AD
Huang, Y., Wang, Y. F., Miao, J., Zheng, R. F., & Li, J. Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116601 · Cited by 70 · cited 1×
“SCFAs help preserve blood–brain barrier (BBB) Studies indicate that autistic children exhibit lower overall SCFA levels, with a particularly preventing neurotoxic substances from entering the brain [51].”
Njotto, L. L., Simin, J., Fornes, R., Odsbu, I., Mussche, I., Callens, S. F. J., Engstrand, L. G., Bruyndonckx, R., & Brusselaers, N. (2023) · Drug Safety · doi:10.1007/s40264-023-01297-1 · Cited by 70 · cited 1×
“The relationship between maternal and early-life antibiotic exposure and autism risk is still unclear, but patients with a history of antibiotic overuse, which can drastically change the composition of their gut microbiota, may also be candidates for FMT [131–133].”
Billeci, L., Callara, A. L., Guiducci, L., Prosperi, M., Morales, M. A., Calderoni, S., Muratori, F., & Santocchi, E. (2023) · Autism · doi:10.1177/13623613221082710 · Cited by 69 · cited 1×
“These findings highlight the need for further investigation into the underlying mechanisms [129].”
Gut microbiota modulates stress-induced hypertension through the HPA axis
Wu, Q. J., Xu, Z., Song, S., Zhang, H., Zhang, W., Liu, L., Chen, Y., & Sun, J. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.05.014 · Cited by 66 · cited 1×
“This disruption results in the increased production of glucocorticoids and catecholamines, causing hypercortisolemia and HPA axis overactivation, often accompanied by impaired glucocorticoid receptor function [85,86].”
Feng, P., Zhao, S., Zhang, Y., & Li, E. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1123462 · Cited by 62 · cited 1×
“Finally, they can enhance gastrointestinal health by alleviating common symptoms such as constipation and bloating, which are frequently observed in individuals with ASD [126].”
Carpita, B., Marazziti, D., Palego, L., Giannaccini, G., Betti, L., & Dell’Osso, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190328151539 · Cited by 60 · cited 1×
“Recent evidence suggests that alterations in the gut microbiota, immune system, and neurodevelopment are closely interconnected and may interact with each other [6].”
The Intestinal Microbiota May Be a Potential Theranostic Tool for Personalized Medicine
Domenico, M. D., Ballini, A., Boccellino, M., Scacco, S., Lovero, R., Charitos, I. A., & Santacroce, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040523 · Cited by 57 · cited 1×
“The human gut microbiome is estimated to contain over 100 trillion bacteria, with their density increasing along the digestive tract and reaching approximately 10 12 –10 14 bacteria per gram of tissue in the colon [20,22].”
Osman, A., Mervosh, N. L., Strat, A. N., Euston, T. J., Zipursky, G., Pollak, R. M., Meckel, K. R., Tyler, S. R., Chan, K. L., Grice, A. B., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.020 · Cited by 53
Nutritional Psychiatry: How Diet Affects Brain through Gut Microbiota
Grosso, G. (2021) · Nutrients · doi:10.3390/nu13041282 · Cited by 52 · cited 1×
“This system encompasses interactions between the gut-associated immune system, the enteric nervous system (ENS), the vagus nerve, and microbial-derived products, including neurotransmitters, SCFAs, and bile acid derivatives [40,41].”
Early Life Exposure to Antibiotics and Autism Spectrum Disorders: A Systematic Review
the SAWANTI Working Group, Łukasik, J., Patro-Gołąb, B., Horvath, A., Baron, R., & Szajewska, H. (2019) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-04093-y · Cited by 51
Olivito, I., Avolio, E., Minervini, D., Soda, T., Rocca, C., Angelone, T., Iaquinta, F. S., Bellizzi, D., Rango, F. D., Bruno, R., et al. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114432 · Cited by 51
Wang, X., Hu, R., Lin, F. H., Yang, T., Lu, Y., Sun, Z., Li, T., & Chen, J. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115212 · Cited by 50
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO
Tu, R., & Xia, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230203140805 · Cited by 47 · cited 1×
“TMAO has been implicated in cardiovascular diseases, contributing to platelet hyperreactivity, increased thrombosis risk, and endothelial dysfunction [63–65].”
Wasiak, J., & Gawlik-Kotelnicka, O. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114459 · Cited by 47 · cited 2×
“Within the body, LPS is recognized by Toll-like LGS allows microbial components like lipopolysaccharide (LPS), toxic metabolites, and inflammatory agents to enter the blood-stream [44,45]. receptors (TLRs), particularly belong to the pattern recognition receptors (PPR) family.”
Self-citationGut Microbiota Profiles in Children and Adolescents with Psychiatric Disorders
Šoltýsová, M., Tomova, A., & Ostatníková, D. (2022) · Microorganisms · doi:10.3390/microorganisms10102009 · Cited by 47
Gut Microbiota and Autism Spectrum Disorder: A Neuroinflammatory Mediated Mechanism of Pathogenesis?
Zarimeidani, F., Rahmati, R., Mostafavi, M., Darvishi, M., Khodadadi, S., Mohammadi, M., Shamlou, F., Bakhtiyari, S., & Alipourfard, I. (2024) · Inflammation · doi:10.1007/s10753-024-02061-y · Cited by 47 · cited 1×
“Firmicutes , which includes Lactobacillus , and Bacteroidetes , which includes Barnesiella and Butyricimonas spp., influence S100B values [95].”
The Gut Microbiota’s Role in Neurological, Psychiatric, and Neurodevelopmental Disorders
Charitos, I. A., Inchingolo, A. M., Ferrante, L., Inchingolo, F., Inchingolo, A. D., Castellaneta, F., Cotoia, A., Palermo, A., Scacco, S., & Dipalma, G. (2024) · Nutrients · doi:10.3390/nu16244404 · Cited by 44 · cited 2×
“Disruptions in endocrine signaling due to an imbalanced gut microbiome may contribute to ASD-related behaviors and altered feeding patterns [43].”
Quan, L., Yi, J., Zhao, Y., Zhang, F., Shi, X.-T., Feng, Z., & Miller, H. L. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2019.10.012 · Cited by 44
Between Dysbiosis, Maternal Immune Activation and Autism: Is There a Common Pathway?
Suprunowicz, M., Tomaszek, N., Urbaniak, A., Zackiewicz, K., Modzelewski, S., & Waszkiewicz, N. (2024) · Nutrients · doi:10.3390/nu16040549 · Cited by 44 · cited 1×
“It is hypothesized that disturbances in GABAergic neuron activity play a role in the development of the disorder [90].”
Exploring Dietary Interventions in Autism Spectrum Disorder
Pérez-Cabral, I. D., Bernal-Mercado, A. T., Islas-Rubio, A. R., Suárez-Jiménez, G. M., Robles-García, M. Á., Puebla-Duarte, A. L., & Del‐Toro‐Sánchez, C. L. (2024) · Foods · doi:10.3390/foods13183010 · Cited by 44 · cited 2×
“Moreover, this highlights a critical opportunity for dietary interventions and other potential treatments to restore microbial balance and improve overall well-being in individuals with ASD [87,118].”
Antioxidant interventions in autism spectrum disorders: A meta-analysis
Liu, Y., Yang, Z., Du, Y., Shi, S., & Cheng, Y. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110476 · Cited by 44 · cited 1×
“Dietary interventions show potential in improving gut health and reducing inflammation, which may alleviate ASD symptoms [119,124,125].”
De Sales-Millán, A., Aguirre-Garrido, J. F., González-Cervantes, R. M., & Velázquez-Aragón, J. A. (2023) · doi:10.20944/preprints202305.1223.v1 · Cited by 44 · cited 1×
“These findings provide a comprehensive understanding of the dysbiotic characteristics of the intestinal microbiota in individuals with ASD, offering novel insights into potential diagnostic and therapeutic interventions for this condition [89,91,92].”
Hao, C., Gao, Z., Liu, X., Rong, Z., Jia, J., Kang, K., Guo, W., & Li, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-77085-z · Cited by 43 · cited 1×
“Priopionic acid (PA) has been shown to promote neuroregeneration through mechanisms involving free fatty acid receptor signaling and the inhibition of class I/II histone deacetylase (HDAC) activity [54].”
Caputi, V., Hill, L., Figueiredo, M., Popov, J., Hartung, E., Margolis, K. G., Baskaran, K., Joharapurkar, P., Moshkovich, M., & Pai, N. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1341656 · Cited by 41 · cited 1×
“These findings provide a comprehensive understanding of the dysbiotic characteristics of the intestinal microbiota in individuals with ASD, offering novel insights into potential diagnostic and therapeutic interventions for this condition [89,91,92].”
Indika, N.-L. R., Deutz, N. E. P., ENGELEN, M. P. K. J., Peiris, H., Wijetunge, S., & Perera, R. (2021) · Biochimie · doi:10.1016/j.biochi.2021.02.018 · Cited by 40 · cited 1×
“These metabolic disturbances may impair remethylation and methylation capacity, potentially affecting nervous system function and exacerbating ASD symptoms [19].”
Zafirovski, K., Aleksoska, M. T., Thomas, J., & Hanna, F. S. (2024) · Children · doi:10.3390/children11070862 · Cited by 39
Plasma Trimethylamine N-Oxide (TMAO): Associations with Cognition, Neuroimaging, and Dementia
Yaqub, A., Vojinovic, D., Vernooij, M. W., Slagboom, P. E., Ghanbari, M., Beekman, M., van der Grond, J., Hankemeier, T., van Duijn, C. M., Ikram, M. A., et al. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01480-1 · Cited by 37 · cited 1×
“However, the effects of TMAO on brain function remain inconclusive, as a large-scale study found no significant association between TMAO levels and cognitive decline [67].”
Agarwala, S., Naik, B., & Ramachandra, N. B. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100269 · Cited by 35
Gut microbiota and autism spectrum disorders: a bidirectional Mendelian randomization study
Li, Z., Liu, S., Liu, F., Dai, N., Liang, R., Lv, S., & Bao, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1267721 · Cited by 34 · cited 3×
“However, Li et al. have demonstrated a possibility for a negative correlation between the occurrence of ASD and the family Prevotellaceae [52,89,117].”
From “Leaky Gut” to Impaired Glia-Neuron Communication in Depression
Rudzki, L., & Maes, M. H. J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_9 · Cited by 33
Interventions on Microbiota: Where Do We Stand on a Gut–Brain Link in Autism? A Systematic Review
Prosperi, M., Santocchi, E., Guiducci, L., Frinzi, J., Morales, M. A., Tancredi, R., Muratori, F., & Calderoni, S. (2022) · Nutrients · doi:10.3390/nu14030462 · Cited by 31 · cited 5×
“Similarly, probiotic therapies and FMT have demonstrated efficacy in enhancing microbial diversity, reducing digestive issues, and improving behavioral functioning [134,135,145].”
InfluentialMłynarska, E., Budny, E., Saar, M., Wojtanowska, E., Jankowska, J., Marciszuk, S., Mazur, M., Rysz, J., & Franczyk, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910429 · Cited by 31 · cited 1×
“Additionally, some researchers have identified a third enterotype, which is characterized by the predominance of Ruminococcus [30].”
Self-citationTomaszek, N., Urbaniak, A. D., Bałdyga, D., Chwesiuk, K., Modzelewski, S., & Waszkiewicz, N. (2025) · Nutrients · doi:10.3390/nu17030486 · Cited by 30 · cited 3×
“Moreover, this highlights a critical opportunity for dietary interventions and other potential treatments to restore microbial balance and improve overall well-being in individuals with ASD [87,118].”
The Role of the Gut Microbiota and the Immune System in the Development of Autism
Lungba, R. M., Khan, S. Z. A., Ajibawo-Aganbi, U., Bastidas, M. V. P., Veliginti, S., Saleem, S., & Cancarevic, I. (2020) · Cureus · doi:10.7759/cureus.11226 · Cited by 30 · cited 1×
“…levels of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α ), interleukin-8 (IL-8), and interleukin-6 (IL-6), as well as increased concentrations of certain anti-inflammatory cytokines, such as interleukin-4 (IL-4) and interleukin-10 (IL-10), in children with ASD [7].”
Li, Z., Chen, Y., & Ke, H. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.08.047 · Cited by 25
Meguid, N. A., Mawgoud, Y. I. A., Bjørklund, G., Mehanne, N. S., Anwar, M., Effat, B. A. E.-K., Chirumbolo, S., & Elrahman, M. M. A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02963-8 · Cited by 24 · cited 1×
“Clinically, 80% of children experienced reduced anxiety and improved sleep, alongside better scores on the Childhood Autism Rating Scale (CARS) and the Pediatric Gastrointestinal Symptoms Questionnaire [127].”
Microbiota and Autism: A Review on Oral and Gut Microbiome Analysis Through 16S rRNA Sequencing
Anaclerio, F., Minelli, M., Antonucci, I., Gatta, V., & Stuppia, L. (2024) · Biomedicines · doi:10.3390/biomedicines12122686 · Cited by 24 · cited 1×
“…achieve the goals of restoring gut barrier integrity, enhancing SCFA production, modulating immune and inflammatory responses, neurotransmitter production, and improving gut microbial diversity, all of which are crucial for supporting gut health and alleviating ASD-related symptoms [114,139–144].”
Dossaji, Z., Khattak, A., Tun, K. M., Hsu, M., Batra, K., & Hong, A. S. (2023) · Microorganisms · doi:10.3390/microorganisms11030806 · Cited by 22 · cited 1×
“Further research is essential to validate the efficacy, safety, and long-term effects of FMT in ASD, as well as to better understand its mechanisms, individual variability, and other challenges [136,137].”
Liu, Y., Yu, J., Yang, Y., Han, B., Wang, Q., & Du, S. (2024) · BMC Genomics · doi:10.1186/s12864-024-10377-0 · Cited by 18
Delzenne, N. M., & Rodriguez, J. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_588 · Cited by 18 · cited 2×
“An overview of the variables impacting the microbiome makeup in adults is provided in Figure 1 [31–39].”
Yang, K.-L., Yen, T., Lin, F., Hsu, C., & Wang, C. (2024) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-024-00774-4 · Cited by 12
Açıkel, S. B., Kara, A., Bağcı, Z., & Can, Ü. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10287 · Cited by 8
Relationships between Gut Microbiota and Autism Spectrum Disorders: Development and Treatment
Poupard, L., Page, G., Thoreau, V., & Kaouah, Z. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.24.1179 · Cited by 6 · cited 1×
“Furthermore, certain bacterial strains, including Lactobacillus and Bifidobacterium, have been observed to modulate the production of neurotransmitters such as GABA [94].”
Cited by
Translocation of bacteria from the gut to the brain in mice
Thapa, M., Kumari, A. R., Chin, C., Choby, J. E., Akbari, E., Bogati, B., Jin, F., Furr, E., Chopyk, D. M., Koduri, N., et al. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003652 · Cited by 39
Kadiyska, T., Vassilev, D. I., Tourtourikov, I., Ciurinskiene, S., Madzharova, D., Savcheva, M., Stoynev, N., Mileva-Popova, R., Tafradjiiska-Hadjiolova, R. K., & Mitev, V. (2025) · Nutrients · doi:10.3390/nu17111775 · Cited by 25
“Microbial metabolites—short-chain fatty acids (SCFAs; acetate, propionate, butyrate), aromatic compounds, free amino acids, and neurotransmitters such as γ -aminobutyric acid (GABA)—are key signaling molecules [6,13].”
Akhtar, A., & Rahaman, S. B. (2025) · Brain Sciences · doi:10.3390/brainsci15080853 · Cited by 27
“Furthermore, dietary imbalance can also destroy the flora of the gut, and even useful bacteria may lose their abundance [80].”
Galvis, C. A. N., Trejos-Gallego, D. M., Correa-Salazar, C., Triviño-Valencia, J., Buitrago, M. V., Ruiz-Pulecio, A. F., Méndez-Ramírez, L. F., Zabaleta, J., Meñaca-Puentes, M. A., Villa, C. A. R., et al. (2025) · Nutrients · doi:10.3390/nu17162664 · Cited by 18
“Multi-strain combinations are recommended by recent meta-analyses as they provide complementary metabolic and immune functions, enhancing overall therapeutic impact [8,27–29].”
Aliuş, C., Breazu, A., Panţu, C., Toader, C., Șerban, M., Covache-Busuioc, R.-A., Munteanu, O., & Dumitru, A. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210959 · Cited by 12
Metadata
- Authors
- Młynarska, E., Barszcz, E., Budny, E., Gajewska, A., Kopeć, K., Wasiak, J., Rysz, J., & Franczyk, B.
- Affiliations
- Medical University of Lodz (PL)
- Corresponding author
- Młynarska, Ewelina
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2025-03-25
- Volume
- 17
- Issue
- 7
- Pages
- 1135
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC11990867
- OpenAlex
- W4408830734
- Cited by
- 44
- References
- 144
- Citations by year
- 2026: 29 · 2025: 15
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- autism spectrum disorder, gut-brain axis, gut microbiota, dysbiosis, short-chain fatty acids, neurotransmitter modulation, neuroinflammation, gastrointestinal symptoms, behavioral symptoms, gluten-free diet, antioxidant diet, probiotics, fecal microbiota transplantation, personalized treatment, microbiome diversity
- MeSH terms
- Autism Spectrum Disorder, Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Brain-Gut Axis, Brain, Humans, Probiotics, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
